{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:08Z","timestamp":1789632188548,"version":"build-2803163510"},"reference-count":40,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15804","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:10:35Z","timestamp":1785928235000},"page":"1-18","source":"Crossref","is-referenced-by-count":0,"title":["DHX15 as a novel immune\u2011related prognostic biomarker in breast cancer: An integrated bioinformatics analysis with\n                    <i>in vitro<\/i>\n                    functional validation"],"prefix":"10.3892","volume":"32","author":[{"given":"Fan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300384, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"key20260917101227_b1-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA J Clin"},{"key":"key20260917101227_b2-ol-32-4-15804","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20260917101227_b3-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.18888.1","article-title":"Triple-negative breast cancer: Recent treatment advances","volume":"8","author":"Bergin","year":"2019","journal-title":"F1000Res"},{"key":"key20260917101227_b4-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"900","DOI":"10.20892\/j.issn.2095-3941.2020.0523","article-title":"Breast cancer incidence and mortality in women in China: Temporal trends and projections to 2030","volume":"18","author":"Lei","year":"2021","journal-title":"Cancer Biol Med"},{"key":"key20260917101227_b5-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA J Clin"},{"key":"key20260917101227_b6-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/ijmm.2026.5729","article-title":"ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review)","volume":"57","author":"Chen","year":"2026","journal-title":"Int J Mol Med"},{"key":"key20260917101227_b7-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.1016\/j.isci.2023.108571","article-title":"A helicase-independent role of DHX15 promotes MYC stability and acute leukemia cell survival","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"key20260917101227_b8-ol-32-4-15804","first-page":"234","article-title":"Relationship between DHX15 expression and survival in colorectal cancer","volume":"115","author":"Fan","year":"2023","journal-title":"Rev Esp Enferm Dig"},{"key":"key20260917101227_b9-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3389\/fimmu.2019.02903","article-title":"Co-expression networks identify DHX15 RNA helicase as a B cell regulatory factor","volume":"10","author":"Detanico","year":"2019","journal-title":"Front Immunol"},{"key":"key20260917101227_b10-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41423-022-00852-7","article-title":"The RNA helicase DHX15 is a critical regulator of natural killer-cell homeostasis and functions","volume":"19","author":"Wang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"key20260917101227_b11-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/pros.23773","article-title":"DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations","volume":"79","author":"Xu","year":"2019","journal-title":"Prostate"},{"key":"key20260917101227_b12-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.humpath.2018.10.006","article-title":"Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma","volume":"84","author":"Xie","year":"2019","journal-title":"Hum Pathol"},{"key":"key20260917101227_b13-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"89643","DOI":"10.18632\/oncotarget.20288","article-title":"DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"key20260917101227_b14-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/bjc.2017.273","article-title":"RNA helicase DHX15 acts as a tumour suppressor in glioma","volume":"117","author":"Ito","year":"2017","journal-title":"B J Cancer"},{"key":"key20260917101227_b15-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12964-025-02225-9","article-title":"Role of DEAD\/DEAH-box helicases in immunity, infection and cancers","volume":"23","author":"Balaya","year":"2025","journal-title":"Cell Commun Signal"},{"key":"key20260917101227_b16-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1002\/jcp.26912","article-title":"The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer","volume":"234","author":"Hashemi","year":"2019","journal-title":"J Cell Physiol"},{"key":"key20260917101227_b17-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"key20260917101227_b18-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"key20260917101227_b19-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gyorffy","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101227_b20-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","article-title":"ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients","volume":"145","author":"Fekete","year":"2019","journal-title":"Int J Cancer"},{"key":"key20260917101227_b21-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: Analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"key20260917101227_b22-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"key20260917101227_b23-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"key20260917101227_b24-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: A cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"key20260917101227_b25-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1612461","DOI":"10.3389\/fimmu.2025.1612461","article-title":"GPATCH3, a splicing regulator that facilitates tumor immune evasion via the modulation of ATPase activity of DHX15","volume":"16","author":"Ren","year":"2025","journal-title":"Front Immunol"},{"key":"key20260917101227_b26-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/onc.2017.371","article-title":"DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor","volume":"37","author":"Jing","year":"2018","journal-title":"Oncogene"},{"key":"key20260917101227_b27-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.3390\/ijms25073716","article-title":"Identification of Dhx15 as a major regulator of liver development, regeneration, and tumor growth in zebrafish and mice","volume":"25","author":"Portoles","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260917101227_b28-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s11658-023-00448-7","article-title":"CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-kappaB p65 positive feedback loop","volume":"28","author":"Zheng","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"key20260917101227_b29-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"118565","DOI":"10.1016\/j.biopha.2025.118565","article-title":"TME-responsive nanoparticles co-targeting VCP, NETs, and dual immune checkpoints for immune revitalization in EGFR\/PD-L1\/CTLA-4-driven colorectal cancer","volume":"192","author":"Lo","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"key20260917101227_b30-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/cells10020223","article-title":"Immune infiltrates in breast cancer: Recent updates and clinical implications","volume":"10","author":"Dieci","year":"2021","journal-title":"Cells"},{"key":"key20260917101227_b31-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol Cancer"},{"key":"key20260917101227_b32-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-020-05954-2","article-title":"Immune microenvironment in different molecular subtypes of ductal breast carcinoma","volume":"185","author":"Sadeghalvad","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"key20260917101227_b33-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune escape in breast cancer during in situ to invasive carcinoma transition","volume":"7","author":"Del Alcazar","year":"2017","journal-title":"Cancer Discov"},{"key":"key20260917101227_b34-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1650726","DOI":"10.3389\/fimmu.2025.1650726","article-title":"Molecular characterization and prognostic modeling associated with M2-like tumor-associated macrophages in breast cancer: Revealing the immunosuppressive role of DLG3","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"key20260917101227_b35-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"155458","DOI":"10.1016\/j.prp.2024.155458","article-title":"M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1","volume":"260","author":"Zhang","year":"2024","journal-title":"Pathol Res Pract"},{"key":"key20260917101227_b36-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/v16121913","article-title":"DHX15 and Rig-I coordinate apoptosis and innate immune signaling by antiviral RNase L","volume":"16","author":"Ramnani","year":"2024","journal-title":"Viruses"},{"key":"key20260917101227_b37-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"ra40","DOI":"10.1126\/scisignal.2004841","article-title":"The DEAH-box RNA helicase DHX15 activates NF-kappaB and MAPK signaling downstream of MAVS during antiviral responses","volume":"7","author":"Mosallanejad","year":"2014","journal-title":"Sci Signal"},{"key":"key20260917101227_b38-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"600573","DOI":"10.3389\/fonc.2020.600573","article-title":"Immune checkpoint inhibitors in triple negative breast cancer treatment: Promising future prospects","volume":"10","author":"Thomas","year":"2020","journal-title":"Front Oncol"},{"key":"key20260917101227_b39-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.omtn.2019.09.028","article-title":"Long non-coding RNA JHDM1D-AS1 interacts with DHX15 protein to enhance non-small-cell lung cancer growth and metastasis","volume":"18","author":"Yao","year":"2019","journal-title":"Mol Ther Nucl Acids"},{"key":"key20260917101227_b40-ol-32-4-15804","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41419-025-07776-w","article-title":"ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma","volume":"16","author":"Ye","year":"2025","journal-title":"Cell Death Dis"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:08Z","timestamp":1789629188000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15804","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}